跳至主要内容
临床试验/CTRI/2018/08/015485
CTRI/2018/08/015485尚未招募2 期

Clinical Evaluation of Drakshasava in theManagement of Pandu (Iron DeficiencyAnaemia)

Central council for research in Ayurvedic Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients of either sex aged between18 to 50 years.
  • 2.IDA documented by hematologic indices.
  • I.Hb 8gm-10gm. %
  • II.S.Ferritin < 12 ng /mL
  • III.TIBC >450mcg/dL
  • IV.S.Iron <60μg/dL for male; <50 for female
  • V.MCV <80fL/redcell VI. RDW >46fL
  • VII.Reticulocyte count <0.5%
  • (Among these the first 3 are the essential criteria for inclusion)
  • 3.Willing and able to participate for 112 days

排除标准

  • 1.Iron deficiency likely or definitely due to blood loss from the intestine or other sites.
  • 2.History or evidence of intestinal malabsorption
  • 3.Major co-morbidity such as a CAD,DM,Malignancies and Auto immune disorders apparent on history, physical examination, or laboratory tests
  • 4.Other causes of anemia (sickle cell disease, thalassemia, other hemolytic anemia, bone marrow failure, etc.) apparent by history, physical examination, and/or laboratory tests.
  • 5.Liver enzymes, AST/ALT > 2 x the upper limit; serum creatinine more than the upper limit.
  • 6.Patients on prolonged ( > 6 weeks) medication that may have an influence on the outcome of the study
  • 7.Patients suffering from Hypothyroidism or Hyperthyroidism.
  • 8.Patients who are already on iron pills for Iron deficiency Anaemia.
  • 9.Other medical or social factors at discretion of treating physician

研究者

相似试验